Jared M. Freedberg

General Counsel at Intercept Pharmaceuticals

Jared M. Freedberg serves as the General Counsel. Mr. Freedberg was previously General Counsel and Secretary of Immunomedics, Inc. Prior to joining Immunomedics, Mr. Freedberg served as General Counsel, Specialty Generics Operating Division, and Vice President, Legal, Business Development and Licensing at Mallinckrodt Pharmaceuticals. From 2001 through 2016, he held positions of increasing responsibility at Covance Inc. and was a member of Covance's Global Executive Leadership Team as Head of Strategy and Business Development from 2014 to 2016. Mr. Freedberg received a Juris Doctor from Duke University School of Law and a bachelor’s degree from the University of Pennsylvania.


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Intercept Pharmaceuticals

1 followers

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.